Sodium-glucose co-transporter-2 inhibitors and protection from cardiovascular death: Is it all about heart failure?

被引：2
|
作者：
Caruso, Irene [1 ]
Cignarelli, Angelo [1 ]
Laviola, Luigi [1 ]
Giorgino, Francesco [1 ]
机构：
[1] Univ Bari Aldo Moro, Sect Internal Med Endocrinol Androl & Metab Dis, Dept Emergency & Organ Transplantat, Piazza Giulio Cesare 11, I-70124 Bari, Italy
来源：
DIABETES OBESITY & METABOLISM | 2021年 / 23卷 / 09期
关键词：
METAANALYSIS;
D O I：
10.1111/dom.14444
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2194 / 2196
页数：3
相关论文
共 50 条
  • [1] The Evolution of Sodium-Glucose Co-Transporter-2 Inhibitors in Heart Failure
    Fadiran, Olusayo
    Nwabuo, Chike
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (11)
  • [2] Beyond the myocardium: Sodium-glucose co-transporter-2 inhibitors in heart failure
    Chilton, Robert J.
    [J]. DIABETES OBESITY & METABOLISM, 2021, 23 (05): : 1215 - 1218
  • [3] The Role of Sodium-Glucose Co-Transporter-2 Inhibitors on Diuretic Resistance in Heart Failure
    Stachteas, Panagiotis
    Nasoufidou, Athina
    Patoulias, Dimitrios
    Karakasis, Paschalis
    Karagiannidis, Efstratios
    Mourtzos, Michail-Angelos
    Samaras, Athanasios
    Apostolidou, Xanthi
    Fragakis, Nikolaos
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (06)
  • [4] Sodium-glucose co-transporter-2 inhibitors in the treatment of diabetes with heart failure COMMENT
    Liang, Bo
    Gu, Ning
    [J]. CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [5] Eligibility of outpatients with chronic heart failure for sodium-glucose co-transporter-2 inhibitors
    Angelini, Gianmarco
    Albanese, Miriam
    Ursi, Raffaella
    Lisi, Francesco
    Bellino, Maria Consiglia
    Amato, Luca
    Gioia, Margherita Ilaria
    Parisi, Giuseppe
    Brunetti, Natale Daniele
    Piazzolla, Giuseppina
    Ciccone, Marco Matteo
    Iacoviello, Massimo
    [J]. ESC HEART FAILURE, 2021, 8 (04): : 2951 - 2958
  • [6] Cardiovascular protection with sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: Does it apply to all patients?
    Giorgino, Francesco
    Vora, Jiten
    Fenici, Peter
    Solini, Anna
    [J]. DIABETES OBESITY & METABOLISM, 2020, 22 (09): : 1481 - 1495
  • [7] Sodium-glucose co-transporter-2 inhibitors as oral antidiabetic in patients wit heart failure
    Jose Morgado, J.
    Roa Garrido, J. R. G.
    Rodriguez Ortega, P. R. O.
    Martinez Mora, B. M. M.
    Camacho Freire, S. C. F.
    Moraleda Salas, T. M. S.
    Lopez Suarez, A. L. S.
    Diaz Fernandez, J. D. F.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 452 - 452
  • [8] What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?
    Khan, Muhammad Shahzeb
    Vaduganathan, Muthiah
    [J]. CURRENT DIABETES REPORTS, 2020, 20 (11)
  • [9] Sodium-glucose co-transporter-2 inhibitors in the non-diabetic heart failure patient
    Essa, Hani
    Walker, Lauren
    Sankaranarayanan, Rajiv
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (06) : 2566 - 2570
  • [10] What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?
    Muhammad Shahzeb Khan
    Muthiah Vaduganathan
    [J]. Current Diabetes Reports, 2020, 20
12345